2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Frank L.J. Visseren(University Medical Center Utrecht)

European Heart Journal

August 30, 2021

10.1093/eurheartj/ehab484

Cited by 6,122

Related Papers

Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia

|New England Journal of Medicine|2008|1.2k

Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population

|Circulation|2016|275

Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score

|Heart|2013|265

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

|Cardiovascular Diabetology|2021|204

Estimating treatment effects for individual patients based on the results of randomised clinical trials

|BMJ|2011|178